Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class ...

Retrieved on: 2024-09-18 19:28:58

Tags for this article:

Click the tags to see associated articles and topics

Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class .... View article details on hiswai:

Excerpt

PRNewswire/ -- Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results from its ...

Article found on: www.prnewswire.com